Analytical Data
-
基因名
AFUA_4G09580
- Application
-
别名
Allergen Asp f II Allergen: Asp f 2
-
种属
Neosartorya fumigata
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P79017
-
表达区间
17-310aa
-
分子量
47.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AFUA_4G09580 is a gene located in the filamentous fungus Aspergillus fumigatus, a significant human pathogen known for causing severe respiratory infections, particularly in immunocompromised individuals. The study of AFUA_4G09580 is driven by the need to understand its functional role in the biology of A. fumigatus, particularly in the context of its pathogenicity, stress response, and adaptation to hostile environments. Investigating the recombinant protein it encodes can provide insights into the mechanisms by which this fungus evades host defenses and establishes infection. Furthermore, understanding the structure and function of the AFUA_4G09580 protein may reveal novel therapeutic targets, as current antifungal treatments are limited and often result in resistance. The identification of unique aspects of this protein could lead to the development of innovative antifungal strategies. Overall, research on AFUA_4G09580 is pivotal not only for advancing our knowledge of A. fumigatus biology but also for addressing the growing challenge of antifungal resistance in clinical settings.
